This is a UK news story, published by University College London Hospitals NHS Foundation Trust, that relates primarily to Vaccine news.
For more UK news, you can click here:
more UK newsFor more Vaccine news, you can click here:
more Vaccine newsFor more vaccine development news, you can click here:
more vaccine development newsFor more news from University College London Hospitals NHS Foundation Trust, you can click here:
more news from University College London Hospitals NHS Foundation TrustOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like this article about vaccine development, you might also like this article about
investigational mRNA cancer immunotherapy. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest cancer vaccines news, lung cancer patient news, news about vaccine development, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
lung cancerUniversity College London Hospitals NHS Foundation Trust
•
71% Informative
First time this immunotherapy made by BioNTech will be studied in a clinical trial for lung cancer in the UK .
BNT116 utilises a messenger RNA (mRNA) to present common tumour markers from NSCLC to the patient’s immune system.
Vaccine is designed to enhance immune responses against targets primarily expressed by cancer cells.
NHS England has a leading role globally in trialling cancer vaccines.
If successful, they could be revolutionary in vaccinating people against their own cancers.
NHS England national cancer director Dame Cally Palmer said: “A cancer diagnosis is very worrying, but access to groundbreaking trials alongside other innovations to diagnose and treat cancers earlier provides hope.
VR Score
72
Informative language
72
Neutral language
62
Article tone
semi-formal
Language
English
Language complexity
57
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
medium-lived
External references
no external sources
Source diversity
no sources
Affiliate links
no affiliate links